Navigation Links
The nose knows in asthma
Date:2/19/2014

It has become increasingly clear in recent years that asthma comes in several variations, with different causes, different pathologies and different responses to therapy. These subtypes of asthma can be identified by knowing which genes are expressed at higher and lower levels in patients' airways. That information can, in turn, help guide personalized treatment to more effectively manage asthma and inspire research to better understand, manage, and possibly prevent asthma.

The difficulty is that tissue samples necessary for this kind of genetic profiling are currently obtained from the airways, which requires bronchoscopy, an invasive procedure involving sedation. Concerns about safety, sedation, and expense limits the use of bronchoscopy, especially among children, and thus the asthmatic tissue samples needed for genetic profiling

Max Seibold, PhD, assistant professor of genetics at National Jewish Health, and his colleagues recently described a less invasive, less expensive and safer way to obtain genetic profiles of asthmatic patients. In the Journal of Allergy and Clinical Immunology, they recently demonstrated that genes expressed in the nasal passages can serve as accurate proxies for those expressed deeper in the airways. Tissue samples can be obtained from nasal passages with a small brush.

Dr. Seibold and his colleagues showed that gene expression in the nasal passages overlaps 90% with genes expressed in the lungs. The researchers were able to distinguish asthmatic from non-asthmatic patients based on genes expressed in the nasal passages. They were also able to distinguish allergic asthma from non-allergic asthma, and associate high levels of the IL-13 gene with asthma exacerbations.

If these findings are confirmed with additional research, genetic profiles of asthmatic patients could become more a more common and valuable tool to guide both therapy and research.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Page: 1

Related biology news :

1. The electronic nose knows when your cantaloupe is ripe
2. How a common fungus knows when to attack
3. The nose knows: Gene therapy restores sense of smell in mice
4. Amiigo Unveils Fitness Tracker That Knows What Exercise Youre Performing
5. Internet helps ensure mother knows best when it comes to preventing childhood obesity
6. Exposure to antibiotics linked to severity of allergic asthma: UBC research
7. Scientists discover new type of cell with a key role in treatment-resistant asthma
8. Leading childhood asthma group supports federal asthma action plan to reduce disparities
9. Infants exposed to specific molds have higher asthma risk
10. Hope on the horizon for asthma sufferers
11. Abuse during childhood linked to adult-onset asthma in African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... 14, 2017   Micralyne Inc., a ... primary supplier of sensors, is pleased to announce ... California to develop and manufacture custom ... joint development of this technology leverages the specific ... flexible and cost effective Metal TSV solution for ...
(Date:6/14/2017)... ... June 13, 2017 , ... ... understanding the phenotype of an organism on a molecular level that is ... data processing remain major bottlenecks to biomarker discovery in clinical-based metabolomics research. ...
(Date:6/13/2017)... , ... June 13, 2017 , ... ... City Science Center’s Phase 1 Ventures (P1V) program. PolyCeramX, Recensa Therapeutics and Regennera, ... and commercialization activities. , Phase 1 Ventures is a startup accelerator that ...
(Date:6/13/2017)... London UK (PRWEB) , ... June 13, 2017 , ... ... and Study on Clinical Trial Participation (CISCRP) and the Society for Clinical Research Sites ... will provide background on the purpose of eConsent and the ability for eConsent to ...
Breaking Biology Technology: